Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals
In this prospective study, our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously. There were three groups (he...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2002-12, Vol.21 (3), p.243-246 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 246 |
|---|---|
| container_issue | 3 |
| container_start_page | 243 |
| container_title | Vaccine |
| container_volume | 21 |
| creator | Sönmez, Emine Sönmez, Ali Suha Bayindir, Yaşar Coskun, Diler Aritürk, Sedat |
| description | In this prospective study, our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously.
There were three groups (healthy individuals, pregnant women, hemodialysis patients), each was divided into two subgroups as groups A and B. Group A received S2SRHB+TT and group B received only S2SRHB.
We found that in groups receiving both vaccines, both seroconversion rate and antibody titer level were significantly higher (
P |
| doi_str_mv | 10.1016/S0264-410X(02)00452-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72737856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X02004528</els_id><sourcerecordid>72737856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-9354142bde1aab00465dd3900452c4492f4b4f9eddf86257db97c73f53d7d6dc3</originalsourceid><addsrcrecordid>eNqFkUFrFTEUhYMo9ln9CUpAlLoYTTLJZLKSWqoWCi5UcBcyyR2aMpN5JpnXFv988948rLhoV5d7-e7hHA5CLyl5TwltPnwnrOEVp-TXEWHvCOGCVe0jtKKtrCsmaPsYrf4iB-hZSpeEEFFT9RQdUMYFaZRaoT_HIfsLWJvss0_4E46Q1lNIgPOE_71vjLU-ADZu9MGnDBEcTn6ch2wCTHMabvCVzxc4QznMqfxfT95hH3CYwqLqIJbd-Y13sxnSc_SkLwNe7Och-vn59MfJ1-r825ezk-PzyvK2zpWqBaecdQ6oMV1J2gjnarWLbDlXrOcd7xU417cNE9J1SlpZ96J20jXO1ofo7aK7jtPvGVLWo08WhmExriWTtWxF8yBI24az4qaAR_eDghCpJJeqoK__Qy-nOYaSV1OuiJKUka2gWCgbp5Qi9Hod_WjijaZEb_vWu771tkxNmN6F1235e7VXn7sR3N3XvuACvNkDJlkz9NEE69MdxwkrNmjhPi4clCI2HqJO1kOw4HwEm7Wb_ANWbgF9Dcjs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490971204</pqid></control><display><type>article</type><title>Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Sönmez, Emine ; Sönmez, Ali Suha ; Bayindir, Yaşar ; Coskun, Diler ; Aritürk, Sedat</creator><creatorcontrib>Sönmez, Emine ; Sönmez, Ali Suha ; Bayindir, Yaşar ; Coskun, Diler ; Aritürk, Sedat</creatorcontrib><description>In this prospective study, our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously.
There were three groups (healthy individuals, pregnant women, hemodialysis patients), each was divided into two subgroups as groups A and B. Group A received S2SRHB+TT and group B received only S2SRHB.
We found that in groups receiving both vaccines, both seroconversion rate and antibody titer level were significantly higher (
P<0.05).
In conclusion, simultaneous administration of S2SRHB+TT is more effective than administration of S2SRHB alone.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(02)00452-8</identifier><identifier>PMID: 12450699</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age ; Antibodies, Viral - blood ; Biological and medical sciences ; Female ; Fundamental and applied biological sciences. Psychology ; Hemodialysis ; Hepatitis ; Hepatitis B - immunology ; Hepatitis B - prevention & control ; Hepatitis B vaccine ; Hepatitis B Vaccines - administration & dosage ; Hepatitis B Vaccines - immunology ; Hepatitis B virus ; Humans ; Injections ; Male ; Microbiology ; Middle Aged ; Nonresponder ; Prospective Studies ; Response rates ; Tetanus ; Tetanus toxoid ; Tetanus Toxoid - administration & dosage ; Tetanus Toxoid - immunology ; Vaccination ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies ; Vaccines, Combined - administration & dosage ; Vaccines, Combined - immunology ; Vaccines, Synthetic - administration & dosage ; Vaccines, Synthetic - immunology ; Virology</subject><ispartof>Vaccine, 2002-12, Vol.21 (3), p.243-246</ispartof><rights>2002 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Limited Dec 13, 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-9354142bde1aab00465dd3900452c4492f4b4f9eddf86257db97c73f53d7d6dc3</citedby><cites>FETCH-LOGICAL-c483t-9354142bde1aab00465dd3900452c4492f4b4f9eddf86257db97c73f53d7d6dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1490971204?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14021491$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12450699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sönmez, Emine</creatorcontrib><creatorcontrib>Sönmez, Ali Suha</creatorcontrib><creatorcontrib>Bayindir, Yaşar</creatorcontrib><creatorcontrib>Coskun, Diler</creatorcontrib><creatorcontrib>Aritürk, Sedat</creatorcontrib><title>Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>In this prospective study, our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously.
There were three groups (healthy individuals, pregnant women, hemodialysis patients), each was divided into two subgroups as groups A and B. Group A received S2SRHB+TT and group B received only S2SRHB.
We found that in groups receiving both vaccines, both seroconversion rate and antibody titer level were significantly higher (
P<0.05).
In conclusion, simultaneous administration of S2SRHB+TT is more effective than administration of S2SRHB alone.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hemodialysis</subject><subject>Hepatitis</subject><subject>Hepatitis B - immunology</subject><subject>Hepatitis B - prevention & control</subject><subject>Hepatitis B vaccine</subject><subject>Hepatitis B Vaccines - administration & dosage</subject><subject>Hepatitis B Vaccines - immunology</subject><subject>Hepatitis B virus</subject><subject>Humans</subject><subject>Injections</subject><subject>Male</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Nonresponder</subject><subject>Prospective Studies</subject><subject>Response rates</subject><subject>Tetanus</subject><subject>Tetanus toxoid</subject><subject>Tetanus Toxoid - administration & dosage</subject><subject>Tetanus Toxoid - immunology</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</subject><subject>Vaccines, Combined - administration & dosage</subject><subject>Vaccines, Combined - immunology</subject><subject>Vaccines, Synthetic - administration & dosage</subject><subject>Vaccines, Synthetic - immunology</subject><subject>Virology</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUFrFTEUhYMo9ln9CUpAlLoYTTLJZLKSWqoWCi5UcBcyyR2aMpN5JpnXFv988948rLhoV5d7-e7hHA5CLyl5TwltPnwnrOEVp-TXEWHvCOGCVe0jtKKtrCsmaPsYrf4iB-hZSpeEEFFT9RQdUMYFaZRaoT_HIfsLWJvss0_4E46Q1lNIgPOE_71vjLU-ADZu9MGnDBEcTn6ch2wCTHMabvCVzxc4QznMqfxfT95hH3CYwqLqIJbd-Y13sxnSc_SkLwNe7Och-vn59MfJ1-r825ezk-PzyvK2zpWqBaecdQ6oMV1J2gjnarWLbDlXrOcd7xU417cNE9J1SlpZ96J20jXO1ofo7aK7jtPvGVLWo08WhmExriWTtWxF8yBI24az4qaAR_eDghCpJJeqoK__Qy-nOYaSV1OuiJKUka2gWCgbp5Qi9Hod_WjijaZEb_vWu771tkxNmN6F1235e7VXn7sR3N3XvuACvNkDJlkz9NEE69MdxwkrNmjhPi4clCI2HqJO1kOw4HwEm7Wb_ANWbgF9Dcjs</recordid><startdate>20021213</startdate><enddate>20021213</enddate><creator>Sönmez, Emine</creator><creator>Sönmez, Ali Suha</creator><creator>Bayindir, Yaşar</creator><creator>Coskun, Diler</creator><creator>Aritürk, Sedat</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20021213</creationdate><title>Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals</title><author>Sönmez, Emine ; Sönmez, Ali Suha ; Bayindir, Yaşar ; Coskun, Diler ; Aritürk, Sedat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-9354142bde1aab00465dd3900452c4492f4b4f9eddf86257db97c73f53d7d6dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hemodialysis</topic><topic>Hepatitis</topic><topic>Hepatitis B - immunology</topic><topic>Hepatitis B - prevention & control</topic><topic>Hepatitis B vaccine</topic><topic>Hepatitis B Vaccines - administration & dosage</topic><topic>Hepatitis B Vaccines - immunology</topic><topic>Hepatitis B virus</topic><topic>Humans</topic><topic>Injections</topic><topic>Male</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Nonresponder</topic><topic>Prospective Studies</topic><topic>Response rates</topic><topic>Tetanus</topic><topic>Tetanus toxoid</topic><topic>Tetanus Toxoid - administration & dosage</topic><topic>Tetanus Toxoid - immunology</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</topic><topic>Vaccines, Combined - administration & dosage</topic><topic>Vaccines, Combined - immunology</topic><topic>Vaccines, Synthetic - administration & dosage</topic><topic>Vaccines, Synthetic - immunology</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sönmez, Emine</creatorcontrib><creatorcontrib>Sönmez, Ali Suha</creatorcontrib><creatorcontrib>Bayindir, Yaşar</creatorcontrib><creatorcontrib>Coskun, Diler</creatorcontrib><creatorcontrib>Aritürk, Sedat</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sönmez, Emine</au><au>Sönmez, Ali Suha</au><au>Bayindir, Yaşar</au><au>Coskun, Diler</au><au>Aritürk, Sedat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2002-12-13</date><risdate>2002</risdate><volume>21</volume><issue>3</issue><spage>243</spage><epage>246</epage><pages>243-246</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>In this prospective study, our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously.
There were three groups (healthy individuals, pregnant women, hemodialysis patients), each was divided into two subgroups as groups A and B. Group A received S2SRHB+TT and group B received only S2SRHB.
We found that in groups receiving both vaccines, both seroconversion rate and antibody titer level were significantly higher (
P<0.05).
In conclusion, simultaneous administration of S2SRHB+TT is more effective than administration of S2SRHB alone.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12450699</pmid><doi>10.1016/S0264-410X(02)00452-8</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2002-12, Vol.21 (3), p.243-246 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72737856 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Adolescent Adult Age Antibodies, Viral - blood Biological and medical sciences Female Fundamental and applied biological sciences. Psychology Hemodialysis Hepatitis Hepatitis B - immunology Hepatitis B - prevention & control Hepatitis B vaccine Hepatitis B Vaccines - administration & dosage Hepatitis B Vaccines - immunology Hepatitis B virus Humans Injections Male Microbiology Middle Aged Nonresponder Prospective Studies Response rates Tetanus Tetanus toxoid Tetanus Toxoid - administration & dosage Tetanus Toxoid - immunology Vaccination Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Vaccines, Combined - administration & dosage Vaccines, Combined - immunology Vaccines, Synthetic - administration & dosage Vaccines, Synthetic - immunology Virology |
| title | Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T16%3A15%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antihepatitis%20B%20response%20to%20hepatitis%20B%20vaccine%20administered%20simultaneously%20with%20tetanus%20toxoid%20in%20nonresponder%20individuals&rft.jtitle=Vaccine&rft.au=S%C3%B6nmez,%20Emine&rft.date=2002-12-13&rft.volume=21&rft.issue=3&rft.spage=243&rft.epage=246&rft.pages=243-246&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/S0264-410X(02)00452-8&rft_dat=%3Cproquest_cross%3E72737856%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1490971204&rft_id=info:pmid/12450699&rft_els_id=S0264410X02004528&rfr_iscdi=true |